130 related articles for article (PubMed ID: 33399042)
1. Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency and Gametocytemia in a Pre-Elimination, Low Malaria Transmission Setting in Southern Zambia.
Kobayashi T; Kurani S; Hamapumbu H; Stevenson JC; Thuma PE; Moss WJ;
Am J Trop Med Hyg; 2021 Jan; 104(3):1000-1002. PubMed ID: 33399042
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
[TBL] [Abstract][Full Text] [Related]
3. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Valencia SH; Ocampo ID; Arce-Plata MI; Recht J; Arévalo-Herrera M
Malar J; 2016 May; 15(1):291. PubMed ID: 27225440
[TBL] [Abstract][Full Text] [Related]
4. An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa.
Chen I; Poirot E; Newman M; Kandula D; Shah R; Hwang J; Cohen JM; Gosling R; Rooney L
Malar J; 2015 May; 14():204. PubMed ID: 25971688
[TBL] [Abstract][Full Text] [Related]
5. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
[TBL] [Abstract][Full Text] [Related]
6. Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa.
van Beek SW; Svensson EM; Tiono AB; Okebe J; D'Alessandro U; Gonçalves BP; Bousema T; Drakeley C; Ter Heine R
Parasit Vectors; 2021 Oct; 14(1):524. PubMed ID: 34627346
[TBL] [Abstract][Full Text] [Related]
7. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
Recht J; Ashley EA; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006230. PubMed ID: 29672516
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial.
Raman J; Allen E; Workman L; Mabuza A; Swanepoel H; Malatje G; Frean J; Wiesner L; Barnes KI
Malar J; 2019 Jun; 18(1):209. PubMed ID: 31234865
[TBL] [Abstract][Full Text] [Related]
11. G6PD deficiency: global distribution, genetic variants and primaquine therapy.
Howes RE; Battle KE; Satyagraha AW; Baird JK; Hay SI
Adv Parasitol; 2013; 81():133-201. PubMed ID: 23384623
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre, Eastern Ethiopia.
Shenkutie TT; Nega D; Hailu A; Kepple D; Witherspoon L; Lo E; Negash MT; Adamu A; Gebremichael SG; Gidey B; Tasew G; Feleke SM; Kebede T
Malar J; 2022 Sep; 21(1):260. PubMed ID: 36076204
[TBL] [Abstract][Full Text] [Related]
13. Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data.
Stepniewska K; Allen EN; Humphreys GS; Poirot E; Craig E; Kennon K; Yilma D; Bousema T; Guerin PJ; White NJ; Price RN; Raman J; Martensson A; Mwaiswelo RO; Bancone G; Bastiaens GJH; Bjorkman A; Brown JM; D'Alessandro U; Dicko AA; El-Sayed B; Elzaki SE; Eziefula AC; Gonçalves BP; Hamid MMA; Kaneko A; Kariuki S; Khan W; Kwambai TK; Ley B; Ngasala BE; Nosten F; Okebe J; Samuels AM; Smit MR; Stone WJR; Sutanto I; Ter Kuile F; Tine RC; Tiono AB; Drakeley CJ; Gosling R; Stergachis A; Barnes KI; Chen I
BMC Med; 2022 Sep; 20(1):350. PubMed ID: 36109733
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination.
Tabatabaei SM; Salimi Khorashad A; Sakeni M; Raeisi A; Metanat Z
J Infect Dev Ctries; 2015 Mar; 9(3):289-97. PubMed ID: 25771467
[TBL] [Abstract][Full Text] [Related]
15. Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
Awandu SS; Raman J; Makhanthisa TI; Kruger P; Frean J; Bousema T; Niemand J; Birkholtz LM
Malar J; 2018 Mar; 17(1):120. PubMed ID: 29558929
[TBL] [Abstract][Full Text] [Related]
16. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
[TBL] [Abstract][Full Text] [Related]
17. Clinical Spectrum of Primaquine-induced Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficiency: A 9-Year Hospitalization-based Study From the Brazilian Amazon.
Brito-Sousa JD; Santos TC; Avalos S; Fontecha G; Melo GC; Val F; Siqueira AM; Alecrim GC; Bassat Q; Lacerda MVG; Monteiro WM
Clin Infect Dis; 2019 Sep; 69(8):1440-1442. PubMed ID: 30753364
[TBL] [Abstract][Full Text] [Related]
18. Primaquine for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
[TBL] [Abstract][Full Text] [Related]
19. G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria.
Satyagraha AW; Sadhewa A; Baramuli V; Elvira R; Ridenour C; Elyazar I; Noviyanti R; Coutrier FN; Harahap AR; Baird JK
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003602. PubMed ID: 25746733
[TBL] [Abstract][Full Text] [Related]
20. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
